Tumor endothelial cell-derived Sfrp1 supports the maintenance of cancer stem cells via Wnt signaling
In Vitro Cellular & Developmental Biology - Animal · 2024-12 · 60 (10) · 1123-1131
DOI: 10.1007/s11626-024-00899-y ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, online erschienen am 16.04.2024. Verfasst von Yumiko Hayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Vascular Biology, Faculty of Medical Science, Fukui University, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Yoshida, Fukui, 910-119…. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Neoplastic Stem Cells, Intercellular Signaling Peptides and Proteins, Membrane Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Precursory Research for Embryonic Science and Technology, Fusion Oriented REsearch for disruptive Science and Technology.
Abstract (Originalsprache)
Cancer stem cells (CSCs), which are critical targets for cancer therapy as they are involved in drug resistance to anticancer drugs, and metastasis, are maintained by angiocrine factors produced by particular niches that form within tumor tissue. Secreted frizzled-related protein 1 (Sfrp1) is an extracellular protein that modulates Wnt signaling. However, the cells that produce Sfrp1 in the tumor environment and its function remain unclear. We aimed to elucidate angiocrine factors related to CSC maintenance, focusing on Sfrp1. Although Sfrp1 is a Wnt pathway-related factor, its impact on tumor tissues remains unknown. We investigated the localization of Sfrp1 in tumors and found that it is expressed in some tumor vessels. Analysis of mice lacking Sfrp1 showed that tumor growth was suppressed in Sfrp1-deficient tumor tissues. Flow cytometry analysis indicated that CSCs were maintained in the early tumor growth phase in the Sfrp1 knockout (KO) mouse model of tumor-bearing cancer. However, tumor growth was inhibited in the late tumor growth phase because of the inability to maintain CSCs. Real-time PCR results from tumors of Sfrp1 KO mice showed that the expression of Wnt signaling target genes significantly decreased in the late stage of tumor growth. This suggests that Sfrp1, an angiocrine factor produced by the tumor vascular niche, is involved in Wnt signaling-mediated mechanisms in tumor tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Vascular Biology, Faculty of Medical Science, Fukui University, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Yoshida, Fukui, 910-1193, Japan.
- Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
- Laboratory for Embryogenesis, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
- Laboratory for Embryology, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
- World Premier Institute Immunology Frontier Research Center, Integrated Frontier Research for Medical Science Division, Osaka University, Suita, Japan.
- Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan.
Förderung
- Japan Society for the Promotion of Science
- Precursory Research for Embryonic Science and Technology
- Fusion Oriented REsearch for disruptive Science and Technology
- University of Fukui
- Institute for Enzyme Research, University of Tokushima
Zitieren
APA
Hayashi, Y., Hashimoto, M., Takaoka, K., Takemoto, T., Takakura, N., & Kidoya, H. (2024). Tumor endothelial cell-derived Sfrp1 supports the maintenance of cancer stem cells via Wnt signaling. In Vitro Cellular & Developmental Biology - Animal, 60(10), 1123-1131. https://doi.org/10.1007/s11626-024-00899-y
Vancouver
Hayashi Y, Hashimoto M, Takaoka K, Takemoto T, Takakura N, Kidoya H. Tumor endothelial cell-derived Sfrp1 supports the maintenance of cancer stem cells via Wnt signaling. In Vitro Cellular & Developmental Biology - Animal. 2024;60(10):1123-1131. doi:10.1007/s11626-024-00899-y
BibTeX
@article{Hayashi2024,
author = {Hayashi, Yumiko and Hashimoto, Masakazu and Takaoka, Katsuyoshi and Takemoto, Tatsuya and Takakura, Nobuyuki and Kidoya, Hiroyasu},
title = {Tumor endothelial cell-derived Sfrp1 supports the maintenance of cancer stem cells via Wnt signaling},
journal = {In Vitro Cellular & Developmental Biology - Animal},
year = {2024},
volume = {60},
number = {10},
pages = {1123--1131},
doi = {10.1007/s11626-024-00899-y}
}
EUVIMED